STUDIES ON THE INDUCTION OF CYCLOOXYGENASE ISOZYMES BY VARIOUS PROSTAGLANDINS IN MOUSE OSTEOBLASTIC CELL-LINE WITH REFERENCE TO SIGNAL-TRANSDUCTION PATHWAYS
Y. Takahashi et al., STUDIES ON THE INDUCTION OF CYCLOOXYGENASE ISOZYMES BY VARIOUS PROSTAGLANDINS IN MOUSE OSTEOBLASTIC CELL-LINE WITH REFERENCE TO SIGNAL-TRANSDUCTION PATHWAYS, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1212(2), 1994, pp. 217-224
A mouse osteoblastic cell line MC3T3-E1 has a cyclooxygenase enzyme, a
nd produces prostaglandin E(2). When the cells were cultured in the pr
esence of iloprost (a stable analogue of prostacyclin) or prostaglandi
n E(1) or F-2a, the activity of cyclooxygenase increased in a dose- an
d time-dependent manner. The increase of the enzyme activity was attri
buted mostly to the cyclooxygenase isoform-2 because immunoprecipitati
on using an anti-cyclooxygenase-2 antibody removed the majority of the
cyclooxygenase activity from the solubilized enzyme fraction, and the
corresponding activity was detected in the immunoprecipitant. In addi
tion, there was a marked increase in the cyclooxygenase-2 protein whic
h was demonstrated by Western blotting. As analyzed by Northern blotti
ng, the cyclooxygenase-2 mRNA increased and reached a maximum 1 and 3
h after the addition of iloprost and prostaglandin F-2a (about 15- and
60-fold increase), respectively, whereas the cyclooxygenase-1 mRNA in
creased slowly and only by about 3-fold. Iloprost and prostaglandin E(
1) stimulated the production of cAMP by 60-fold over the basal level,
whereas the cAMP level was almost unchanged by prostaglandin F-2a In c
ontrast, prostaglandin F-2a stimulated IP3 production more efficiently
than iloprost and prostaglandin E(1). These results suggest that the
stimulated syntheses prominently of cyclooxygenase-2 and to a lesser e
xtent of cyclooxygenase-1 are mediated by at least two distinct signal
transduction pathways involving the cAMP-synthesis stimulated by ilop
rost and prostaglandin E(1) and the phosphoinositide turnover stimulat
ed by prostaglandin F-2a.